Volume 13, Issue 1 (1-2015)                   IJRM 2015, 13(1): 41-48 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoradmehr A, Danafar A, Halvaei I, Golzadeh J, Hosseini M, Mirjalili T et al . Effect of prenatal methamphetamine administration during gestational days on mice. IJRM. 2015; 13 (1) :41-48
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-584-en.html
1- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
3- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , moanvari@yahoo.com
Abstract:   (521 Views)
Background: Methamphetamine (MA) is one of most common illicit drugs which were reported that nearly half of MA consumers are women. MA can cross through placenta and affects pregnancy and fetus development.
Objective: Our aim was to evaluate effects of injected MA on crown-rump length, head and placental circumference, body weight, histological changes and apoptosis in fetus.
Materials and Methods: Twenty-four NMRI pregnant mice were randomly divided into five groups. First, second and third groups were injected intraperitoneally 10 mg/kg/day MA during gestational days (GD): GD1-7, GD8-14, and GD1-14, respectively. Forth group, as sham, was injected saline from GD1-14, and finally control which was received neither MA nor saline. On GD15 cervical dislocated pregnant mice, fetus and placenta were weighed and fetus crown-rump length was measured. Hematoxylin and Eosin staining and TUNEL assay were applied to assess histological changes and apoptosis respectively.
Results: Fetus body weight and crown-rump length showed significant decrease in third compared to first and second groups (p≤0.001). There were significant differences in head circumference in control and sham compared to third group (0.5 (0.5-0.6), 0.6 (0.5-0.8), 0.4 (0.4-0.5) cm respectively, p≤0.001). Also fetus that treated with MA showed lower placenta circumference compared to control and sham groups. Histological changes such as exencephaly, hemorrhage and immature fetus were observed in second and third groups. Apoptotic cells in second and third groups were higher than controls, but differences were not significant.
Conclusion: It seems MA abuse during pregnancy can cause morphological and histological changes in mice fetus but the exact mechanism remains unclear.
Full-Text [PDF 485 kb]   (111 Downloads) |   |   Full-Text (HTML)  (112 Views)  
Type of Study: Original Article |

References
1. Anderson M, Choonara I. Drug misuse during pregnancy and fetal toxicity. Arch Dis Child Fetal Neonatal Ed 2007; 92: 332-333. [DOI:10.1136/adc.2006.115303]
2. Narkowicz S, Polkowska Z, Namiesnik J. Analysis of markers of exposure to constituents of environmental tobacco smoke (ETS): Critical Reviews. Anal Chem 2012; 42: 16-37. [DOI:10.1080/10408347.2012.629948]
3. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California (see comments). New Eng J Med 1993; 329: 850-854. [DOI:10.1056/NEJM199309163291207]
4. Moore DG,Turner JJD, Goodwin JE, Fulton SE, Singer LT, Parrott AC. In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, Crystal): preliminary findings. In: Alcohol, Drugs and Medication in Pregnancy: The Outcome for the Child. John Wiley & Sons 2011.
5. Ma J, Wan J, Meng J, Banerjee S, Ramakrishnan S, Roy S. Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor. Cell Death Dis 2014; 5: e1099. [DOI:10.1038/cddis.2014.64]
6. Bennett C, Hyde C, Pecora J, Clodfelter J. Differing neurotoxic potencies of methamphetamine, mazinol, and cocaine in mesencephalic cultures. J Neurochem 1993; 60: 1444-1452. [DOI:10.1111/j.1471-4159.1993.tb03307.x]
7. McKetin R, McLaren J, Lubman D I, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473-1478. [DOI:10.1111/j.1360-0443.2006.01496.x]
8. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJJ, Perstin J, et al. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits and cancer: Review. Toxicol Sci 2009; 108: 4-18. [DOI:10.1093/toxsci/kfn263]
9. Leino O, Kiviranta H, Karjalainen AK, Kronberg-Kippila C, Sinkko H, Larsen EH, et al. Pollutant concentrations in placenta. Food Chem Toxicol 2011; 54: 59-69. [DOI:10.1016/j.fct.2011.10.058]
10. Plotka J, Narkowicz S, Polkowska Z, Biziuk M, Namiesnik J. Effects of addictive substances during pregnancy and infancy and their analysis in biological materials: Reviews. Rev Environ Contam Toxicol 2014: 227.
11. Thompson BL, Levitt P, Stanwood GD. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nature Rev Neurosci 2009; 10: 303-312. [DOI:10.1038/nrn2598]
12. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998; 25: 119-138. [DOI:10.1016/S0889-8545(05)70361-2]
13. Freedman RR, Johnson CE, Tancer ME. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 2005; 183: 248-256. [DOI:10.1007/s00213-005-0149-6]
14. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102: 1204-1211. [DOI:10.1111/j.1360-0443.2007.01874.x]
15. Wouldes T, LaGasse L, Sheridan J, Lester B. Maternal methamphetamine use during pregnancy and child outcome: what do we know? J N Z Med Assoc 2004; 117: 1206.
16. Jeng, W, Wong AW, Ting-A-Kee R, Wells PG. Methamphetamine enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Rad Biol Med 2005; 39: 317-326. [DOI:10.1016/j.freeradbiomed.2005.03.015]
17. Kiernan JA. Histological and Histochemical Methods: Theory and Practice. 4th Ed. Bloxham, UK, Scion; 2008: 20-25.
18. Brecht M-L, Herbeck DM. Pregnancy and Fetal Loss Reported by Methamphetamine-Using Women. Subst Abuse 2014; 8: 25-33. [DOI:10.4137/SART.S14125]
19. Nguyen D, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 2010; 157: 337-339. [DOI:10.1016/j.jpeds.2010.04.024]
20. Kwiatkowski MA, Roos A, Stein DJ, Thomas KGF, Donald K. Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies. Metab Brain Dis 2014; 29: 245-254. [DOI:10.1007/s11011-013-9470-7]
21. Vicentic A, Jones DC. Cocaine and amphetamine regulated transcript system in appetite and drug addiction. J Pharmacol Exp Ther 2007; 320: 499-506. [DOI:10.1124/jpet.105.091512]
22. Kobeissy FH, Jeung JA, Warren MW, Geier JE, Gold MS. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Addiction Biol 2008; 13: 15-25. [DOI:10.1111/j.1369-1600.2007.00083.x]
23. Saito M, Terada M, Saito T, Takahashi K. [Effects of the long-term administration of methamphetamine on body weight, food intake, blood biochemistry and estrous cycle in rats. Exp Anim 1995; 43: 747-754. (In Japanese) [DOI:10.1538/expanim1978.43.5_747]
24. Cappon GD, Vorhees CV. Plasma and brain methamphetamine concentrations in neonatal rats. Neurotoxicol Teratol 2001; 23: 81-88. [DOI:10.1016/S0892-0362(00)00118-5]
25. Cui C, Sakata‐Haga H, Ohta Ki, Nishida M, Yashiki M, Sawada K, et al. Histological brain alterations following prenatal methamphetamine exposure in rats. Congenit Anom (Kyoto) 2006; 46: 180- 187. [DOI:10.1111/j.1741-4520.2006.00126.x]
26. Mirjalili T, Kalantar SM, Lahijani MS, Sheikhha MH, Talebi A. Congenital abnormality effect of methamphetamine on histological, cellular and chromosomal defects in fetal mice. Iran J Reprod Med 2013; 11: 39-46.
27. Moriya F, Hashimoto Y. A case of fatal hemorrhage in the cerebral ventricles following intravenous use of methamphetamine. Forensic Sci Int 2002; 129: 104-109. [DOI:10.1016/S0379-0738(02)00233-5]
28. Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Ohba S. Subcortical hemorrhage caused by methamphetamine abuse: efficacy of the triage system in the differential diagnosis case report. Neurol Med Chir (Tokyo) 2003; 43: 82-84. [DOI:10.2176/nmc.43.82]
29. Quinton MS, Yamamoto BK. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 2006; 8: 337. [DOI:10.1007/BF02854904]
30. Wells PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol 2005; 207: 354-366. [DOI:10.1016/j.taap.2005.01.061]
31. Dixon SD, Bejar R. Echoencephalographic findings in neonates assciiated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatr 1989; 115: 770-778. [DOI:10.1016/S0022-3476(89)80661-4]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb